Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial
- 23 August 2006
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 368 (9538) , 855-863
- https://doi.org/10.1016/s0140-6736(06)69210-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Joint inflammation and cytokine inhibition in rheumatoid arthritisClinical and Experimental Medicine, 2006
- Limiting inflammatory responses during activation of innate immunityNature Immunology, 2005
- The expression of toll‐like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll‐like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cellsArthritis & Rheumatism, 2005
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- Heat Shock Protein 10 Inhibits Lipopolysaccharide-induced Inflammatory Mediator ProductionJournal of Biological Chemistry, 2005
- Expression of Toll‐like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin‐12 and interleukin‐18 via interferon‐γArthritis & Rheumatism, 2004
- Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?Immunological Reviews, 2004
- Development of anti-TNF therapy for rheumatoid arthritisNature Reviews Immunology, 2002
- Unfolding the role of chaperones and chaperonins in human diseaseTrends in Genetics, 2001
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996